Patient selection biomarker strategies for PARP inhibitor therapy

Ann Oncol. 2020 Dec;31(12):1603-1605. doi: 10.1016/j.annonc.2020.09.017. Epub 2020 Oct 1.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers
  • Female
  • Homologous Recombination
  • Humans
  • Ovarian Neoplasms* / drug therapy
  • Patient Selection
  • Poly(ADP-ribose) Polymerase Inhibitors* / therapeutic use

Substances

  • Biomarkers
  • Poly(ADP-ribose) Polymerase Inhibitors